| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012038A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011966A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
| 04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011682A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | WO1997011667A2 Therapeutic applications using horse serum |
| 04/03/1997 | WO1997011666A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | DE19531226C1 Pharmaceutical compsn. for prevention or treatment of viral disease |
| 04/03/1997 | CA2233445A1 2-mercaptoethanolamine, copper di-isopropyl salicylate, and related compounds |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2233015A1 Therapeutic applications using horse serum |
| 04/03/1997 | CA2232950A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | CA2232937A1 Porcine cell interaction proteins |
| 04/03/1997 | CA2230940A1 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765479A1 Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765386A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765333A1 Quillaja saponin adjuvant and vaccine formulation containing same |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765171A1 Treatment of autoimmune and inflammatory disorders |
| 04/02/1997 | EP0765170A1 Composition for inducing a mucosal immune response |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0765163A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0654085B1 Monomeric and dimeric antibody-fragment fusion proteins |
| 04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
| 04/02/1997 | EP0495008B1 Vaccine conjugate for treatment of avian diseases |
| 04/02/1997 | CN1146772A Synthetic peptide based immunogens for the treatment of allergy |
| 04/02/1997 | CN1146730A 抗体纯化 Antibody Purification |
| 04/01/1997 | US5616686 Polypeptide of a hybrid surface protein by bacteria |
| 04/01/1997 | US5616685 snRNP-A antigen and fragments thereof |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616468 Compositions and diagnostic methods using monoclonal antibodies against CD44v6 |
| 04/01/1997 | US5616328 Method of preparing gram-negative bacterial vaccines |
| 04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 04/01/1997 | US5616321 Method of treating bacterial meningitis with anti-tumor necrosis factor antibody |
| 03/27/1997 | WO1997011370A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | WO1997011200A1 Human herpesvirus type 8 isolated from human lymphoma cell line and uses thereof |
| 03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
| 03/27/1997 | WO1997011181A1 Nucleic acid molecules which code proteins which mediate the adhesion of neisseria cells to human cells |
| 03/27/1997 | WO1997011180A1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/27/1997 | WO1997011177A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997010847A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | WO1997010846A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997010845A1 An immunostimulant and antineoplastic glycan obtained from mycobacterium vaccae |
| 03/27/1997 | WO1997010844A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 03/27/1997 | WO1997010832A1 Treatment and prevention of hiv infection and aids with sarcoid-derived antigens |
| 03/27/1997 | WO1997010821A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | WO1997005253A3 Transketolase-related protein |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
| 03/27/1997 | CA2232834A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
| 03/27/1997 | CA2232601A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2232501A1 An immunostimulant and antineoplastic glycan obtained from mycobacterium vaccae |
| 03/27/1997 | CA2232360A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | CA2230127A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | CA2230116A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2227306A1 Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection |
| 03/26/1997 | EP0764658A1 Process for obtaining immunoglobulins from fractions originating from the fractionation of human blood plasma |
| 03/26/1997 | EP0764657A1 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 03/26/1997 | EP0764447A2 Preparation of virally inactivated intravenously injectable immune serum globulin |
| 03/26/1997 | EP0764446A2 An adjuvanted vaccine which is substantially free of non-host albumin |
| 03/26/1997 | EP0764445A2 Acellular vaccine |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764213A1 Recombinant aav genome encoding immunodeficiency virus protein |
| 03/26/1997 | EP0764207A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764048A1 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
| 03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 03/26/1997 | EP0764029A1 Proteinaceous adjuvants |
| 03/26/1997 | EP0546087B1 Protein structure of the plant toxin gelonin |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |
| 03/26/1997 | CN1145909A Anti-ganglioside monoclonal antibodies and their use in specific active immunotherapy of malignant tumors |
| 03/25/1997 | US5614612 Genetic engineering, vaccines, hiv |
| 03/25/1997 | US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |